Neuralink Stock

neuralink.comHealthcare / Medical DevicesFounded: 2016Funding to Date: $645.76MM

Neuralink, founded in July of 2016 by Elon Musk, Max Hodak, and Paul Merolla, is a developer of brain-machine interfaces, building devices designed to help people with paralysis. Neuralink is developing a device, composed of a chip that would be implanted in a person's skull, with electrodes fanning out into their brain, that would be embedded in a person's brain, record brain activity and potentially stimulate it.

Register To Buy and Sell Shares

For more details on financing and valuation for Neuralink, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Neuralink’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Neuralink.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Jared Birchall
Co-Chief Executive Officer, Chief Financial Officer, & President
Elon Musk
Co-Founder & Co-Chief Executive Officer

Frequently Asked Questions About Neuralink’s Stock

Can you buy Neuralink’s stock?
Neuralink is not publicly traded on NYSE or NASDAQ in the U.S. To buy Neuralink’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Neuralink’s stock?
Yes, you can sell stock of a private company like Neuralink. Forge can help you sell your Neuralink stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Neuralink’s stock price?
Neuralink is a privately held company and therefore does not have a public stock price. However, you may access Neuralink’s private market stock price with Forge Data.
What is Neuralink’s stock ticker symbol?
Neuralink does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Elon Musk claims first Neuralink implant patient can already control a mouse with their thoughts
Elon Musk announced that the brain implant patient can control a mouse with their thoughts.
Behind Elon Musk’s Brain Chip: Decades of Research and Lofty Ambitions to Meld Minds with Computers
Billionaire technology investor Elon Musk, who is the CEO of neurotechnology startup Neuralink, announced that the company successfully implanted one of its devices into a human as part of its testing initiatives. Neuralink gained approval from the U.S. Food & Drug Administration in May 2023, which paved the way for human trials of its medical device implants. Musk said the company’s first product is called Telepathy and it enables users to control computers and mobile devices through their thoughts.
Elon Musk's Neuralink raises more cash ahead of human trials next year
Elon Musk's controversial brain implant company Neuralink has raised more funding as it gears up to start human trials. Neuralink has just collected a further $43 million, according to an SEC filing last week. The fresh funding brings the amount raised to more than $323 million, SEC filings show. The latest round was led by billionaire investor Peter Thiel's Founders Fund, TechCrunch reported. A total of 32 investors contributed funds, per the filing.
Updated on: Apr 15, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.